| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/31/2026 | ±2.7% | -1.1% | over-priced |
| 05/01/2026 | ±2.1% | -0.7% | over-priced |
| 02/27/2026 | ±1.8% | +0.2% | over-priced |
| 11/03/2025 | ±2.1% | +0.6% | over-priced |
| 08/04/2025 | ±1.4% | +1.8% | under-priced |
| 05/02/2025 | ±2.1% | +2.0% | over-priced |
| 02/24/2025 | ±1.5% | +2.2% | under-priced |
| 11/04/2024 | ±1.5% | +0.1% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $1.15 | $3.7B | $452M |
| Q1 FY2026 | $1.31 | $3.7B | $515M |
| Q4 FY2025 | — | $3.7B | $450M |
| Q3 FY2025 | $1.28 | $3.8B | $511M |
WRB (WRB) reports in 2 days, with the next report estimated for 10/29/2026. Across the last 8 reports, options priced an average ±1.9% earnings move while the stock actually moved 1.1% on average — the market has systematically over-priced WRB's earnings risk. Fundamentals into the print: EPS up 15.0% year-over-year, revenue up 1.2%. QuantLogix's live 5-factor engine currently reads WRB as a buy at 76/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →